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Abstract
Sequencing of the Leishmania major Friedlin
genome is well underway with chromosome 1
(Chr1) and Chr3 having been completely sequ-
enced, and Chr4 virtually complete. Sequencing
of several other chromosomes is in progress and
the complete genome sequence may be available as
soon as 2003. A large proportion (E 70%) of the
newly identified genes remains unclassified, with
many of these being potentially Leishmania- (or
kinetoplastid-) specific. Most interestingly, the
genes are organized into large ("100–300 kb)
polycistronic clusters of adjacent genes on the
same DNA strand. Chr1 contains two such clus-
ters organized in a ‘divergent’ manner, i.e. the
mRNAs for the two sets of genes are both
transcribed towards the telomeres. Chr3 contains
two ‘convergent’ clusters, with a single ‘diver-
gent’ gene at one telomere, with the two large
clusters separated by a tRNA gene. We have
characterized several genes from the LD1 (Leish-
mania DNA 1) region of Chr35. BT1 (formerly
ORFG) encodes a biopterin transporter and
ORFF encodes a nuclear protein of unknown
function. Immunization of mice with recombinant
antigens from these genes results in significant
reduction in parasite burden following Leishmania
challenge. Recombinant ORFF antigen shows
promise as a serodiagnostic. We have also de-
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veloped a tetracycline-regulated promoter system,
which allows us to modulate gene expression in
Leishmania.
Introduction
The numerous human-infective Leishmania spp.
cause a spectrum of diseases with pathologies
ranging from asymptomatic to lethal, resulting in
widespread human suffering and death, as well as
substantial economic loss. There is a correlation
between the parasite species and disease mani-
festation [1], but host factors play an important
role in disease pathology. Diagnosis of Leishmania
infection is insensitive, non-specific and labour-
intensive; current chemotherapeutic agents are
unsuitable because of their high toxicity, and there
are no approved vaccines. Thus a greater knowl-
edge of Leishmania biochemistry and genetics
is sorely needed. The Leishmania genome size is
E 34 Mb and the chromosomes range in size from
0.3 to 2.8 Mb [2,3]. The Leishmania karyotype is
conserved among Leishmania species (albeit with
considerable size polymorphism) and the genes
are syntenic [2,4,5], except that the Old World
species have 36 chromosomes [2] and the New
World species have 35 (L. braziliensis complex) or
34 (L. mexicana complex) [4].
Genome sequencing
In 1994, the Leishmania Genome Network (LGN)
was set up under the auspices of the World Health
Organization to initiate a Leishmania genome
project, and L. major MHOM}IL}81}Friedlin
(LmjF) was subsequently selected as the reference
strain. A first-generation cosmid contig map of the
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entire genome was constructed [6], and cosmid-
based genomic sequencing began in 1996. The
sequence of the smallest (285 kb) Leishmania
chromosome (Chr1) was completed in 1998, and
79 protein-coding genes were identified [7]. Re-
markably, these genes are organized into two large
polycistronic units, with the first 29 genes on one
DNA strand and the remaining 50 genes on the
other stand, such that their mRNAs are tran-
scribed in a ‘divergent’ manner towards the
telomeres. The 257-kb ‘informational ’ region
(containing the protein-coding genes) is flanked
by telomeric and sub-telomeric sequences that
differ in size by E 29 kb between Chr1 homo-
logues [8]. The sequence of Chr3 (385 kb) has
been completed recently in the U.S.A., as well as
39 cosmids representing E1.2 Mb of the 2.4-Mb
Chr35, and two cosmids each from Chr22, Chr27
and Chr2. In Europe, Chr4 (408 kb), and most of
Chr19 and Chr23 have been completed and sequ-
encing has begun on Chr5, Chr13, Chr14 and
Chr21. Currently, 3.3 Mb of completed sequence
and 2.1 Mb of unfinished sequence has been
submitted to the sequence databases. In addition,
genome survey sequences (GSS) representing
another 4 Mb have been submitted from Wash-
ington University (St. Louis, MO, U.S.A.). The
ongoing sequencing progress can be monitored
using the SBRI Leishgen website (http:}}
204.203.14.2}lmjf) or the LGN website (http:}}
www.ebi.ac.uk}parasites}leish.html).
Gene organization
As was the case with Chr1, the genes on the other
chromosomes are organized into large clusters
Figure 1
Gene organization of Leishmania chromosomes
The gene clusters on Chr1, Chr3, Chr4 and Chr35 are indicated by the thick lines, with the
direction of mRNAs indicated by the arrowheads at the end of each line. The vertical lines at
the right-hand end of Chr1 denote sub-telomeric repeat sequences. The gaps in Chr35
represent regions not yet sequenced.
Chr35
with many genes adjacent on the same DNA
strand (see Figure 1). Interestingly, the gene
clusters can be either divergent (as on Chr1),
where the mRNAs are transcribed toward the
telomeres, or ‘convergent’ (on Chr3 and Chr4),
where they are transcribed away from the telo-
meres. Indeed, it appears that these two organi-
zations may occur on adjacent portions of the same
chromosomes (e.g. Chr3). This gene organization
is consistent with the previously observed poly-
cistronic transcription of protein-coding genes in
Leishmania (and other kinetoplastida) and sub-
sequent processing to form mature mRNAs [9].
Recent nuclear run-on data for LmjF Chr1 sup-
ports this interpretation, since it appears that
transcription of the protein-coding strand is signi-
ficantly greater than that of the non-coding strand
(S. Martinez-Calvillo and P. J. Myler, unpub-
lished work). The processing of the precursor
RNA, which occurs co-transcriptionally [10],
involves co-ordinated 3« polyadenylation of the
upstream mRNA and addition of a 39-nt spliced
leader sequence to the 5« ends of the downstream
mRNAs (trans-splicing). Polypyrimidine tracts
within the intergenic regions provide the signals
for this processing [11,12]. No introns have been
discovered to date within any of the Leishmania
protein-coding genes, although the recent disc-
overy of cis-splicing in other trypanosomatids
[13] suggests that this may not hold true for all
Leishmania genes.
To date, almost 1000 complete genes have
been identified from the cosmid sequencing,
although this number is rapidly increasing and
will no doubt be greater at the time of publication.
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The rRNA genes have been identified, but only
one tRNA gene has been found. Interestingly, it is
located at the junction of two convergent gene
clusters on Chr3. The largest (E70%) gene
category is that of the unclassified genes. Some of
these represent genes encoding predicted proteins
with sequence homology to proteins with un-
known functions in other organisms, or those that
contain uninformative sequence motifs, but most
encode proteins with no identifying features or
sequence similarities (other than to genes in other
trypanosomatids). These may represent genes that
have parasite-specific functions, or which are
diverged sufficiently as to have no significant
sequence similarity to their functional homologues
in other species.
The gene distribution seen on Chr1, Chr3,
Chr4 and Chr35 indicates that Leishmania genes
do not tend to cluster into prokaryote-like operons
of genes with similar function. Interestingly,
however, some regions appear to have a higher-
than-expected concentration of large genes with
no similarity to those in other organisms. The
gene density (1 gene}3.7 kb) observed within the
informational regions of Chr1, Chr3 and Chr4
extrapolates to a total of E8600 protein-coding
genes in the entire Leishmania genome. Given that
E70% of the protein-coding genes have no
currently identified function, it is reasonable to
infer that completion of the Leishmania genome
sequence will identify 4000–5000 genes with po-
tentially parasite-specific functions. Statistical
analyses of the nucleotide content of Chr1 reveals
a striking, non-random purine bias and GC skew
that is correlated with the two polycistronic units
of protein-coding genes [14]. These findings
suggest that novel transcription processes in
Leishmania may be responsible for the nucleotide
bias, which in turn affects chromosomal gene
organization. They also suggest that the junction
region between the two divergent polycistronic
gene clusters on Chr1 may be a candidate for an
origin of DNA replication.
Leishmania DNA 1 (LD1) genes
The LD1 region, which is located E100 kb from
one telomere of Chr35, is amplified in E15%
of Leishmania strains examined [15]. Compari-
son of a 131-kb LmjF sequence with the 35-
kb sequences obtained from L. donovani and
L. infantum [16–18] shows considerably more
sequence conservation (91–96%) within the pro-
tein-coding open reading frames than within the
non-coding regions (79–85%). Using antibodies
against recombinant protein (rORFF), we demon-
strated that ORFF is localized to the parasite
nucleus [19]. Purified rORFF protein was found
to be a more sensitive serodiagnostic than the total
soluble antigen now in common use, and appeared
specific for the L. donovani complex [20]. Im-
munization of mice with rORFF and rORFG
proteins, individually and in combination, showed
that they stimulated both humoral and cellular
responses, and provided a significant degree of
protection against subsequent challenge with L.
donovani, with up to a 60% reduction in liver and
spleen amastigote burdens [21].
Using successive rounds of gene replacement
of the three ORFG genes in L. donovani LSB-51.1
[22], an ORFG-null mutant was obtained. The
null mutants were unable to survive in standard
growth medium without added biopterin, and
showed essentially no uptake of radioactive biop-
terin.Thus ORFG encodes a biopterin transporter
and has been renamed BT1 [23]. These results
suggest that uptake of biopterin by BT1 is critical
for cell survival at physiological concentrations of
biopterin. The BT1-null mutants showed signi-
ficantly slower growth as promastigotes, even in
the presence of supplemental biopterin and folate,
suggesting that their ability to grow in this me-
dium is due to uptake of biopterin via passive
diffusion or a secondary (and lower-affinity) trans-
porter. Conversely, amplification and overexpres-
sion of BT1 confers a significant growth advantage
in both naturally isolated and recombinant cell
lines, perhaps providing the selective pressure for
the frequent amplification of LD1 seen in Leish-
mania isolates [24,25]. This advantage appears to
extend to macrophage infectivity, since the nat-
urally occurring isolates with amplified BT1 show
significantly higher infectivity of macrophages in
vitro, while the null mutant showed a significant
reduction in infectivity.
Development of a regulatable
promoter system in Leishmania
The transcription-initiation site of L. donovani
rRNA genes was mapped 1020 bp upstream of the
18 S rRNA gene and the promoter was func-
tionally characterized using transient-transfection
studies [26]. Three domains (fi76 to fi57, fi46 to
fi27 and fi6 to ›4 relative to the transcription-
initiation site) were found to mediate promoter
activity, suggesting that the rRNA is not dissimilar
to that of other eukaryotes. Similar results were
obtained with the L. major rRNA promoter, which
# 2000 Biochemical Society529
Biochemical Society Transactions (2000) Volume 28, part 5
was active in L. major, L. donovani, L. aethiopica
and L. infantum, while the L. donovani promoter
showed reduced activity in L. major.
In order to adapt the prokaryotic tetracy-
cline-responsive repressor}operator system to L.
donovani, promastigotes expressing the tetra-
cycline-repressor gene in the a-tubulin locus were
transfected with a construct containing a phleo-
mycin-resistance}luciferase fusion gene driven
by the rRNA promoter (PrRNA
tc
) containing two
copies of the tetracycline operator sequence. The
construct was targeted into the rRNA non-tran-
scribed intergenic region in the reverse orientation
relative to transcription of the rRNA gene. This
system showed an increase in luciferase expression
by more than 200-fold in the presence of tetra-
cycline. Comparison with similar constructs (but
lacking PrRNA
tc
) integrated into the a-tubulin
and rRNA loci showed that luciferase expression
driven by the down-regulated PrRNA
tc
(i.e. in the
absence of tetracycline) was E100-fold lower than
expression by pol II (tubulin locus) and E5000-
fold lower than expression by pol I (rRNA locus).
Conversely, luciferase activity driven by the
up-regulated PrRNA
tc
(i.e. in the presence of
tetracycline) was E2–3-fold higher than that from
pol II expression at the tubulin locus.
However, in these first-generation constructs,
even in the absence of tetracycline, the luciferase
activity was E100-fold above background, so
a second-generation construct was developed, in
which the selectable marker (hygromycin resis-
tance) was expressed from an endogenous pro-
moter on the opposite strand to the reporter gene
(luciferase) under control of the tetracycline-
regulated promoter. When targeted into either the
rRNA (Chr27) or LD1 (Chr35) loci, this construct
showed regulation of luciferase expression by
over three orders of magnitude. Clones with the
construct in the rRNA locus showed 10-fold
higher luciferase activities than those in the
LD1 locus, both in the presence and absence of
tetracycline. Integration into the LD1 locus
showed luciferase levels close to background
in the absence of tetracycline. Induction of lu-
ciferase expression was rapid, becoming elevated
by up to two orders of magnitude within 5 h of
tetracycline addition, with full induction by 24 h.
In contrast, luciferase activity decreased 3–4-fold
within 4 h of tetracycline removal, then slowly
declined until it reached background levels after
about 1 week. The level of luciferase activity was
dependent on tetracycline concentration, with a
concentration of 0.1 lg}ml being sufficient for
maximal induction, while 0.001 lg}ml resulted in
little or no induction. This technology is currently
being transferred into LmjF, the Leishmania strain
being sequenced. The ability to tightly regulate
promoter activity will be extremely useful for
studying gene function in Leishmania and several
applications of this inducible system are in prog-
ress.
Conclusions and future directions
The pace of sequence generation in the Leishmania
genome project has increased substantially over
the past year and it is likely that the entire genome
will be complete by 2003. Thus, the next 2
years will see a massive explosion in the number
of Leishmania gene sequences available for study.
Already, serious efforts are underway in several
laboratories to implement the next stages of high-
throughput genome-wide analyses, such as DNA
microarrays [27] and proteomics [28]. When com-
bined with new molecular tools (such as the
regulatable promoter system) for analyses of
Leishmania biology, these studies will probably
cause a paradigm shift in our quest to understand
and control this parasite.
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Abstract
Differentiation between bloodstream and tsetse
midgut procyclic forms during the life cycle of the
African trypanosome is an attractive model for
the analysis of stage-regulated events. In par-
ticular, this transformation occurs synchronously,
there are well-defined markers for stage-regulated
processes and cell lines with specific defects in
differentiation have been identified. This com-
bination of tools, combined with the developing
Trypanosoma brucei genome database is allowing
its underlying controls to be investigated at the
molecular and cytological levels. This paper
examines some recent discoveries that illuminate
some of the key events during trypanosome life-
cycle progression.
Overview
African trypanosomiasis is spread between mam-
malian hosts in sub-Saharan Africa by the blood-
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feeding tsetse fly. The parasite undergoes many
changes as it is transmitted between the blood of a
mammalian host and the gut of the tsetse fly, these
being required for adaptation to the very different
environmental conditions encountered [1]. In
particular, the parasite undergoes metabolic de-
velopment in order to successfully move from the
glucose-rich bloodstream to the tsetse midgut,
where proline is the main energy source [2]. The
trypanosome also changes the major proteins that
comprise its surface coat [3,4] and undergoes
morphological development from the bloodstream
trypomastigote to the tsetse procyclic stage [5].
These changes to the parasite’s biochemistry,
morphology and profile of expressed genes and
proteins are highly regulated and provide a trac-
table system for the analysis of life-cycle differen-
tiation in these evolutionarily ancient protozoan
parasites.
Bloodstream-to-procyclic-form
differentiation provides a model for
the analysis of regulated events in the
trypanosome life cycle
Although trypanosomes grow to high levels of
parasitaemia in infected mammalian hosts, only
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